Musings
Musings on genome medicine: the Obama effect redux
-
* Corresponding author: David G Nathan david_nathan@dfci.harvard.edu
Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
Genome Medicine 2009, 1:86 doi:10.1186/gm86
Published: 11 September 2009Abstract
From the point of view of genome medicine, Barack Obama has made two vital policy decisions: he has chosen a new director of the National Institutes of Health, and his proposed change in United States healthcare policy will have profound effects on genome medicine and, indeed, all of academic medicine.